Towards a Rationale of Platelet Aggregation Monitoring in Stroke Prophylaxis?

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 2, 2009, Pages 111-115

  von Lewinski, Friederike ^a   Riggert, Joachim ^a   Paulus, Walter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

aggregation; aspirin; clopidogrel; Platelet; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CLOPIDOGREL; COLLAGEN; NADROPARIN;

AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ASPIRIN; COLLAGEN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PREVENTIVE MEDICINE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 60749117796     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.09.010     Document Type: Article

References (20)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 7329 (2002) 71-86
2. Bhatt D.L., Fox K.A., Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 16 (2006) 1706-1717
3. Cuisset T., Frere C., Quilici J., et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. Thromb Haemost 4 3 (2006) 542-549
4. Grotemeyer K.H., Scharafinski H.W., and Husstedt I.W. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 71 5 (1993) 397-403
5. Mueller M.R., Salat A., Stangl P., et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78 3 (1997) 1003-1007
6. Grundmann K., Jaschonek K., Kleine B., et al. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 250 1 (2003) 63-66
7. Makaryus A.N. Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease. Clin Cardiol 29 4 (2006) 144-148
8. Matzdorff A. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemost 31 4 (2005) 393-399
9. Harrison P., Frelinger III A.L., Furman M.I., et al. Measuring antiplatelet drug effects in the laboratory. Thromb Res 120 3 (2007) 323-336
10. Snoep J.D., Hovens M.M., Eikenboom J.C., et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Am Heart J 154 2 (2007) 221-231
11. Harrison P., Segal H., Blasbery K., et al. Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 36 5 (2005) 1001-1005
12. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962) 927-929
13. Homoncik M., Jilma B., Hergovich N., et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 83 2 (2000) 316-321
14. Carcao M.D., Blanchette V.S., Dean J.A., et al. The Platelet Function Analyzer (PFA-100): A novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 101 1 (1998) 70-73
15. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138 3 (2001) 152-163
16. Gum P.A., Kottke-Marchant K., Poggio E.D., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88 3 (2001) 230-235
17. Chakroun T., Gerotziafas G., Robert F., et al. In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of plasma von Willebrand factor. Br J Haematol 124 1 (2004) 80-85
18. Kotzailias N., Elwischger K., Sycha T., et al. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients. J Stroke Cerebrovasc Dis 16 5 (2007) 199-202
19. Alberts M.J., Bergman D.L., Molner E., et al. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 35 1 (2004) 175-178
20. Lev E.I., Patel R.T., Maresh K.J., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance. J Am Coll Cardiol 47 1 (2006) 27-33